<li>abobotulinumtoxina<p>lorazepam decreases effects of abobotulinumtoxina by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>acetaminophen<p>lorazepam decreases levels of acetaminophen by increasing metabolism. Minor/Significance Unknown. Enhanced metabolism incr levels of hepatotoxic metabolites.</p></li><li>acetaminophen iv<p>lorazepam decreases levels of acetaminophen iv by increasing metabolism. Minor/Significance Unknown. Enhanced metabolism incr levels of hepatotoxic metabolites.</p></li><li>acetaminophen rectal<p>lorazepam decreases levels of acetaminophen rectal by increasing metabolism. Minor/Significance Unknown. Enhanced metabolism incr levels of hepatotoxic metabolites.</p></li><li>atracurium<p>lorazepam decreases effects of atracurium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>biotin<p>lorazepam decreases levels of biotin by unspecified interaction mechanism. Minor/Significance Unknown. Biotin supplementation may be necessary.</p></li><li>brimonidine<p>brimonidine increases effects of lorazepam by pharmacodynamic synergism. Minor/Significance Unknown. Increased CNS depression.</p></li><li>cisatracurium<p>lorazepam decreases effects of cisatracurium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>cyanocobalamin<p>lorazepam decreases levels of cyanocobalamin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>dexmethylphenidate<p>dexmethylphenidate increases effects of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>esomeprazole<p>esomeprazole increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>eucalyptus<p>lorazepam and eucalyptus both increase  sedation. Minor/Significance Unknown.</p></li><li>fleroxacin<p>fleroxacin increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>gemifloxacin<p>gemifloxacin increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>green tea<p>green tea decreases effects of lorazepam by pharmacodynamic antagonism. Minor/Significance Unknown. Caffeine component of green tea may decrease sedative effects of benzodiazepines.</p></li><li>incobotulinumtoxina<p>lorazepam decreases effects of incobotulinumtoxina by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>levocarnitine<p>lorazepam decreases levels of levocarnitine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>levofloxacin<p>levofloxacin increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>methylphenidate<p>methylphenidate increases effects of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>moxifloxacin<p>moxifloxacin increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>norfloxacin<p>norfloxacin increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>ofloxacin<p>ofloxacin increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>omeprazole<p>omeprazole increases levels of lorazepam by decreasing metabolism. Minor/Significance Unknown.</p></li><li>onabotulinumtoxina<p>lorazepam decreases effects of onabotulinumtoxina by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>pancuronium<p>lorazepam decreases effects of pancuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>pyrimethamine<p>lorazepam, pyrimethamine.
Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive hepatotoxicity.</p></li><li>rapacuronium<p>lorazepam decreases effects of rapacuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>rifabutin<p>rifabutin decreases levels of lorazepam by increasing metabolism. Minor/Significance Unknown.</p></li><li>rimabotulinumtoxinb<p>lorazepam decreases effects of rimabotulinumtoxinb by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>rocuronium<p>lorazepam decreases effects of rocuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>sage<p>lorazepam and sage both increase  sedation. Minor/Significance Unknown.<span><br><br></span>sage decreases effects of lorazepam by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction; some species of sage may cause convulsions.</p></li><li>succinylcholine<p>lorazepam decreases effects of succinylcholine by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>tubocurarine<p>lorazepam decreases effects of tubocurarine by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>vecuronium<p>lorazepam decreases effects of vecuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>vinpocetine<p>lorazepam increases effects of vinpocetine by unspecified interaction mechanism. Minor/Significance Unknown. Desirable interaction  enhanced memory improvement (based on preliminary trial).</p></li><li>zolpidem<p>zolpidem, lorazepam.
Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Additive CNS depression.</p></li>